Charles Bennett to Molecular Targeted Therapy
This is a "connection" page, showing publications Charles Bennett has written about Molecular Targeted Therapy.
Connection Strength
0.120
-
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system. Expert Opin Drug Saf. 2016 Aug; 15(8):1003-11.
Score: 0.120